Christoph Georg Baums
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Christoph Georg Baums has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Peter Valentin-Weigand
Institute for Microbiology, University of Veterinary Medicine Hanover, Hanover, Germany
9 shared publicationsAndreas Beineke
Institute for Pathology, University of Veterinary Medicine Hanover, Hanover, Germany
5 shared publicationsRalph Goethe
Institute for Microbiology, University of Veterinary Medicine Hanover, Hanover, Germany
4 shared publicationsKarl-Heinz Waldmann
Klinik für kleine Klauentiere und forensische Medizin und Ambulatorische Klinik, Stiftung Tierärztliche Hochschule Hannover, D-30173 Hannover, Germany
3 shared publicationsChristoph Kock
Institut für Mikrobiologie, Zentrum für Infektionsmedizin, Stiftung Tierärztliche Hochschule Hannover, D-30173 Hannover, Germany,1 Institut für Pathologie, Stiftung Tierärztliche Hochschule Hannover, D-30173 Hannover, Germany,2 Klinik für kleine Klauentiere und forensische Medizin und Ambulatorische Klinik, Stiftung Tierärztliche Hochschule Hannover, D-30173 Hannover, Germany3
2 shared publicationsMarcus Fulde
Department of Medical Microbiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
2 shared publications
Latest Publications
- Open Access
- 1 June 2014
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 82 (6) , 2460-2471
Role of Capsule and Suilysin in Mucosal Infection of Complement-Deficient Mice with Streptococcus suis
Virulent Streptococcus suis serotype 2 strains are invasive extracellular bacteria causing septicemia and meningitis in piglets and humans. One objective of this study was to elucidate the function of complement in innate immune defense against S. suis . Experimental infection of wild-type (WT) and C3 −/− mice demonstrated for the first time that the complement system protects naive mice against invasive mucosal S. suis infection. S. suis WT but not an unencapsulated mutant caused mortality associated with meningitis and other pathologies in C3 −/− mice. The capsule contributed also substantially to colonization of the upper respiratory tract. Experimental infection of C3 −/− mice with a suilysin mutant indicated that suilysin expression facilitated an early disease onset and the pathogenesis of meningitis. Flow cytometric analysis revealed C3 antigen deposition on the surface of ca. 40% of S. suis WT bacteria after opsonization with naive WT mouse serum, although to a significantly lower intensity than on the unencapsulated mutant. Ex vivo multiplication in murine WT and C3 −/− blood depended on capsule but not suilysin expression. Interestingly, S. suis invasion of inner organs was also detectable in C5aR −/− mice, suggesting that chemotaxis and activation of immune cells via the anaphylatoxin receptor C5aR is, in addition to opsonization, a further important function of the complement system in defense against mucosal S. suis infection. In conclusion, we unequivocally demonstrate here the importance of complement against mucosal S. suis serotype 2 infection and that the capsule of this pathogen is also involved in escape from complement-independent immunity.
- 1 June 2014
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 82 (6) , 2460-2471
Open AccessRole of Capsule and Suilysin in Mucosal Infection of Complement-Deficient Mice with Streptococcus suis
Virulent Streptococcus suis serotype 2 strains are invasive extracellular bacteria causing septicemia and meningitis in piglets and humans. One objective of this study was to elucidate the function of complement in innate immune defense against S. suis . Experimental infection of wild-type (WT) and C3 −/− mice demonstrated for the first time that the complement system protects naive mice against invasive mucosal S. suis infection. S. suis WT but not an unencapsulated mutant caused mortality associated with meningitis and other pathologies in C3 −/− mice. The capsule contributed also substantially to colonization of the upper respiratory tract. Experimental infection of C3 −/− mice with a suilysin mutant indicated that suilysin expression facilitated an early disease onset and the pathogenesis of meningitis. Flow cytometric analysis revealed C3 antigen deposition on the surface of ca. 40% of S. suis WT bacteria after opsonization with naive WT mouse serum, although to a significantly lower intensity than on the unencapsulated mutant. Ex vivo multiplication in murine WT and C3 −/− blood depended on capsule but not suilysin expression. Interestingly, S. suis invasion of inner organs was also detectable in C5aR −/− mice, suggesting that chemotaxis and activation of immune cells via the anaphylatoxin receptor C5aR is, in addition to opsonization, a further important function of the complement system in defense against mucosal S. suis infection. In conclusion, we unequivocally demonstrate here the importance of complement against mucosal S. suis serotype 2 infection and that the capsule of this pathogen is also involved in escape from complement-independent immunity.
- 1 July 2013
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 149 (1) , 94-102
Establishment of a Model of Streptococcus iniae Meningoencephalitis in Nile Tilapia (Oreochromis niloticus)
- 1 July 2013
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 149 (1) , 94-102
Establishment of a Model of Streptococcus iniae Meningoencephalitis in Nile Tilapia (Oreochromis niloticus)
- 1 September 2012
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 61 (9) , 1311-1318
A novel intranasal mouse model for mucosal colonization by Streptococcus suis serotype 2
Streptococcus suis causes meningitis and various other diseases in pigs and humans. Healthy piglets carrying virulent Streptococcus suis strains on their mucosal surfaces are epidemiologically very important. The objective of this study was to establish an intranasal Streptococcus suis mouse model for invasion and colonization of the respiratory tract. CD1 mice were infected intranasally with a highly virulent Streptococcus suis serotype 2 strain under different conditions. Clinical, histological and bacteriological screenings revealed that invasion of host tissue occurred in the majority of mice only after predisposition with 12.5 µl 1 % acetic acid per nostril. Severe fibrinosuppurative or purulent necrotizing pneumonia associated with Streptococcus suis was a common manifestation. Furthermore, a novel model to study nasopharyngeal colonization was established by reducing the volume of 1 % acetic acid per nostril to 5 µl prior to Streptococcus suis application. This model mimics asymptomatic carriage in swine, as all mice carried Streptococcus suis on their respiratory mucosa at 7 days post-infection (p.i.) in moderate to high numbers without the development of pneumonia or any other invasive Streptococcus suis disease. This intranasal Streptococcus suis model was applied to investigate the function of suilysin (SLY) in colonization. Although an isogenic SLY mutant was isolated from the upper respiratory tract at a lower recovery rate than its wild-type parental strain at 14 days p.i., the differences were not significant and did not indicate severe attenuation in colonization. In conclusion, this work describes to the best of our knowledge the first intranasal mouse model to study colonization of the respiratory tract by a highly virulent Streptococcus suis pathotype.
- 1 September 2012
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 61 (9) , 1311-1318
A novel intranasal mouse model for mucosal colonization by Streptococcus suis serotype 2
Streptococcus suis causes meningitis and various other diseases in pigs and humans. Healthy piglets carrying virulent Streptococcus suis strains on their mucosal surfaces are epidemiologically very important. The objective of this study was to establish an intranasal Streptococcus suis mouse model for invasion and colonization of the respiratory tract. CD1 mice were infected intranasally with a highly virulent Streptococcus suis serotype 2 strain under different conditions. Clinical, histological and bacteriological screenings revealed that invasion of host tissue occurred in the majority of mice only after predisposition with 12.5 µl 1 % acetic acid per nostril. Severe fibrinosuppurative or purulent necrotizing pneumonia associated with Streptococcus suis was a common manifestation. Furthermore, a novel model to study nasopharyngeal colonization was established by reducing the volume of 1 % acetic acid per nostril to 5 µl prior to Streptococcus suis application. This model mimics asymptomatic carriage in swine, as all mice carried Streptococcus suis on their respiratory mucosa at 7 days post-infection (p.i.) in moderate to high numbers without the development of pneumonia or any other invasive Streptococcus suis disease. This intranasal Streptococcus suis model was applied to investigate the function of suilysin (SLY) in colonization. Although an isogenic SLY mutant was isolated from the upper respiratory tract at a lower recovery rate than its wild-type parental strain at 14 days p.i., the differences were not significant and did not indicate severe attenuation in colonization. In conclusion, this work describes to the best of our knowledge the first intranasal mouse model to study colonization of the respiratory tract by a highly virulent Streptococcus suis pathotype.
- 30 March 2012
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 146 (3-4) , 191-200
Streptococcus suis serotype 9 bacterin immunogenicity and protective efficacy
- 30 March 2012
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 146 (3-4) , 191-200
Streptococcus suis serotype 9 bacterin immunogenicity and protective efficacy
- Open Access
- 1 January 2011
- Published by Springer Nature in BMC Microbiology
- Vol. 11 (1) , 161
Genetic diversity of Streptococcus suis isolates as determined by comparative genome hybridization
Streptococcus suis is a zoonotic pathogen that causes infections in young piglets. S. suis is a heterogeneous species. Thirty-three different capsular serotypes have been described, that differ in virulence between as well as within serotypes.
- 1 January 2011
- Published by Springer Nature in BMC Microbiology
- Vol. 11 (1) , 161
Open AccessGenetic diversity of Streptococcus suis isolates as determined by comparative genome hybridization
Streptococcus suis is a zoonotic pathogen that causes infections in young piglets. S. suis is a heterogeneous species. Thirty-three different capsular serotypes have been described, that differ in virulence between as well as within serotypes.
- 1 October 2010
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 17 (10) , 1589-1597
Immunogenicity of an AutogenousStreptococcus suisBacterin in Preparturient Sows and Their Piglets in Relation to Protection after Weaning
Streptococcus suisis an important porcine pathogen causing meningitis and other invasive diseases in piglets of different ages. Application ofS. suisserotype 2 bacterins to specific-pathogen-free (SPF) weaning piglets has been demonstrated to protect against the homologous serotype. However, autogenousS. suisbacterins are also applied to sows and suckling piglets in the field. Therefore, comparative evaluation of different bacterin immunization regimes, including sow vaccination, was performed in this study. The main objectives were to determine the immunogenicity of anS. suisbacterin in sows prepartum and its influence on active immunization of piglets. Experimental infection of 6- and 8-week-old weaning piglets was performed to elucidate protective efficacies. Humoral immune responses were investigated by an enzyme-linked immunosorbent assay (ELISA) measuring muramidase-released protein (MRP)-specific IgG titers and by opsonophagocytosis assays. Bacterin application elicited high MRP-specific IgG titers in the serum and colostrum of sows, as well as opsonizing antibodies. Piglets from vaccinated sows had significantly higher MRP-specific titers than respective piglets from nonvaccinated sows until 6 weeks postpartum. Vaccination of suckling piglets did not result in high MRP-specific titers nor in induction of opsonizing antibodies. Furthermore, neither vaccination of suckling nor of weaning piglets from immunized sows was associated with a prominent active immune response and protection at 8 weeks postpartum. However, protection was observed in respective 6-week-old weaning piglets, most likely because of protective maternal immunity. In conclusion, this study provides the first results suggesting protective passive maternal immunity forS. suisserotype 2 after bacterin vaccination of sows and a strong inhibitory effect on active immunization of suckling and weaning piglets, leading to highly susceptible growers.
- 1 October 2010
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 17 (10) , 1589-1597
Immunogenicity of an AutogenousStreptococcus suisBacterin in Preparturient Sows and Their Piglets in Relation to Protection after Weaning
Streptococcus suisis an important porcine pathogen causing meningitis and other invasive diseases in piglets of different ages. Application ofS. suisserotype 2 bacterins to specific-pathogen-free (SPF) weaning piglets has been demonstrated to protect against the homologous serotype. However, autogenousS. suisbacterins are also applied to sows and suckling piglets in the field. Therefore, comparative evaluation of different bacterin immunization regimes, including sow vaccination, was performed in this study. The main objectives were to determine the immunogenicity of anS. suisbacterin in sows prepartum and its influence on active immunization of piglets. Experimental infection of 6- and 8-week-old weaning piglets was performed to elucidate protective efficacies. Humoral immune responses were investigated by an enzyme-linked immunosorbent assay (ELISA) measuring muramidase-released protein (MRP)-specific IgG titers and by opsonophagocytosis assays. Bacterin application elicited high MRP-specific IgG titers in the serum and colostrum of sows, as well as opsonizing antibodies. Piglets from vaccinated sows had significantly higher MRP-specific titers than respective piglets from nonvaccinated sows until 6 weeks postpartum. Vaccination of suckling piglets did not result in high MRP-specific titers nor in induction of opsonizing antibodies. Furthermore, neither vaccination of suckling nor of weaning piglets from immunized sows was associated with a prominent active immune response and protection at 8 weeks postpartum. However, protection was observed in respective 6-week-old weaning piglets, most likely because of protective maternal immunity. In conclusion, this study provides the first results suggesting protective passive maternal immunity forS. suisserotype 2 after bacterin vaccination of sows and a strong inhibitory effect on active immunization of suckling and weaning piglets, leading to highly susceptible growers.
- 29 June 2009
- Published by Cambridge University Press (CUP) in Animal Health Research Reviews
- Vol. 10 (1) , 65-83
Surface-associated and secreted factors ofStreptococcus suisin epidemiology, pathogenesis and vaccine development
Streptococcus suisis an invasive porcine pathogen associated with meningitis, arthritis, bronchopneumonia and other diseases. The pathogen constitutes a major health problem in the swine industry worldwide. Furthermore,S. suisis an important zoonotic agent causing meningitis and other diseases in humans exposed to pigs or pork. Current knowledge on pathogenesis is limited, despite the enormous amount of data generated by ‘omics’ research. Accordingly, immunprophylaxis (in pigs) is hampered by lack of a cross-protective vaccine against virulent strains of this diverse species. This review focuses on bacterial factors, both surface-associated and secreted ones, which are considered to contribute toS. suisinteraction(s) with host factors and cells. Factors are presented with respect to (i) their identification and features, (ii) their distribution amongS. suisand (iii) their significance for virulence, immune response and vaccination. This review also shows the enormous progress made in research onS. suisover the last few years, and it emphasizes the numerous challenging questions remaining to be answered in the future.
- 29 June 2009
- Published by Cambridge University Press (CUP) in Animal Health Research Reviews
- Vol. 10 (1) , 65-83
Surface-associated and secreted factors ofStreptococcus suisin epidemiology, pathogenesis and vaccine development
Streptococcus suisis an invasive porcine pathogen associated with meningitis, arthritis, bronchopneumonia and other diseases. The pathogen constitutes a major health problem in the swine industry worldwide. Furthermore,S. suisis an important zoonotic agent causing meningitis and other diseases in humans exposed to pigs or pork. Current knowledge on pathogenesis is limited, despite the enormous amount of data generated by ‘omics’ research. Accordingly, immunprophylaxis (in pigs) is hampered by lack of a cross-protective vaccine against virulent strains of this diverse species. This review focuses on bacterial factors, both surface-associated and secreted ones, which are considered to contribute toS. suisinteraction(s) with host factors and cells. Factors are presented with respect to (i) their identification and features, (ii) their distribution amongS. suisand (iii) their significance for virulence, immune response and vaccination. This review also shows the enormous progress made in research onS. suisover the last few years, and it emphasizes the numerous challenging questions remaining to be answered in the future.
- 1 February 2009
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 16 (2) , 200-208
Streptococcus suisBacterin and Subunit Vaccine Immunogenicities and Protective Efficacies against Serotypes 2 and 9
Streptococcus suiscauses numerous diseases in pigs, most importantly, meningitis, arthritis, septicemia, and bronchopneumonia. One of the major problems in modern swine production is the lack of a vaccine protecting against more than oneS. suisserotype. The objective of this study was to determine the protective efficacy of a serotype 2 murein-associated protein (MAP) fraction subunit vaccine in comparison to that of a bacterin against experimental challenge with serotype 2 (containing muramidase-released protein [MRP], extracellular factor, and suilysin [SLY]) and serotype 9 (containing MRP variant MRP* and SLY) strains. MAP was shown to include different surface-associated proteins, such as the MRP and surface antigen one (SAO) expressed by both pathotypes used for challenge. The results of this study demonstrated that the serotype 2 bacterin induced protective immunity against homologous challenge. In contrast, the protective efficacy of the MAP subunit vaccine was low, though MAP immunization resulted in high serum immunoglobulin G2 titers against MRP and SAO. Importantly, immunization with bacterin but not with MAP induced opsonizing antibody titers against the serotype 2 strain, and these antibody titers were found to correlate with protection. However, after absorption with a nonencapsulated isogenic mutant, the sera from bacterin-immunized piglets failed to facilitate neutrophil killing, indicating that antibodies directed against capsule may not have been essential for opsonophagocytosis. Furthermore, induction of opsonizing antibodies against serotype 9 was not detectable in the group receiving bacterin or in the group receiving the MAP vaccine. In agreement, protection against the heterologous serotype 9 strain was low in both groups. Thus, identification of an antigen protecting against these two importantS. suispathotypes remains an important goal of future studies.
- 1 February 2009
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 16 (2) , 200-208
Streptococcus suisBacterin and Subunit Vaccine Immunogenicities and Protective Efficacies against Serotypes 2 and 9
Streptococcus suiscauses numerous diseases in pigs, most importantly, meningitis, arthritis, septicemia, and bronchopneumonia. One of the major problems in modern swine production is the lack of a vaccine protecting against more than oneS. suisserotype. The objective of this study was to determine the protective efficacy of a serotype 2 murein-associated protein (MAP) fraction subunit vaccine in comparison to that of a bacterin against experimental challenge with serotype 2 (containing muramidase-released protein [MRP], extracellular factor, and suilysin [SLY]) and serotype 9 (containing MRP variant MRP* and SLY) strains. MAP was shown to include different surface-associated proteins, such as the MRP and surface antigen one (SAO) expressed by both pathotypes used for challenge. The results of this study demonstrated that the serotype 2 bacterin induced protective immunity against homologous challenge. In contrast, the protective efficacy of the MAP subunit vaccine was low, though MAP immunization resulted in high serum immunoglobulin G2 titers against MRP and SAO. Importantly, immunization with bacterin but not with MAP induced opsonizing antibody titers against the serotype 2 strain, and these antibody titers were found to correlate with protection. However, after absorption with a nonencapsulated isogenic mutant, the sera from bacterin-immunized piglets failed to facilitate neutrophil killing, indicating that antibodies directed against capsule may not have been essential for opsonophagocytosis. Furthermore, induction of opsonizing antibodies against serotype 9 was not detectable in the group receiving bacterin or in the group receiving the MAP vaccine. In agreement, protection against the heterologous serotype 9 strain was low in both groups. Thus, identification of an antigen protecting against these two importantS. suispathotypes remains an important goal of future studies.
- 1 February 2007
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 73 (3) , 711-717
Prevalence ofStreptococcus suisGenotypes in Wild Boars of Northwestern Germany
Invasive serotype 2 (cps2+) strains ofStreptococcus suiscause meningitis in pigs and humans. Four case reports ofS. suismeningitis in hunters suggest transmission ofS. suisthrough the butchering of wild boars. Therefore, the objective of this study was to investigate the prevalence of potentially human-pathogenicS. suisstrains in wild boars.S. suiswas isolated from 92% of all tested tonsils (n= 200) from wild boars. A total of 244S. suisisolates were genotyped using PCR assays for the detection of serotype-specific genes, the hemolysin genesly, and the virulence-associated genesmrpandepf. The prevalence of thecps2+genotype among strains from wild boars was comparable to that of control strains from domestic pig carriers. Ninety-five percent of thecps2+wild boar strains were positive formrp,sly, andepf*, the large variant ofepf. Interestingly,epf* was significantly more frequently detected incps2+strains from wild boars than in those from domestic pigs;epf* is also typically found in EuropeanS. suisisolates from humans, including a meningitis isolate from a German hunter. These results suggest that at least 10% of wild boars in Northwestern Germany carryS. suisstrains that are potentially virulent in humans. Additional amplified fragment length polymorphism analysis supported this hypothesis, since homogeneous clustering of theepf*mrp+sly+cps2+strains from wild boars with invasive human and porcine strains was observed.
- 1 February 2007
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 73 (3) , 711-717
Prevalence ofStreptococcus suisGenotypes in Wild Boars of Northwestern Germany
Invasive serotype 2 (cps2+) strains ofStreptococcus suiscause meningitis in pigs and humans. Four case reports ofS. suismeningitis in hunters suggest transmission ofS. suisthrough the butchering of wild boars. Therefore, the objective of this study was to investigate the prevalence of potentially human-pathogenicS. suisstrains in wild boars.S. suiswas isolated from 92% of all tested tonsils (n= 200) from wild boars. A total of 244S. suisisolates were genotyped using PCR assays for the detection of serotype-specific genes, the hemolysin genesly, and the virulence-associated genesmrpandepf. The prevalence of thecps2+genotype among strains from wild boars was comparable to that of control strains from domestic pig carriers. Ninety-five percent of thecps2+wild boar strains were positive formrp,sly, andepf*, the large variant ofepf. Interestingly,epf* was significantly more frequently detected incps2+strains from wild boars than in those from domestic pigs;epf* is also typically found in EuropeanS. suisisolates from humans, including a meningitis isolate from a German hunter. These results suggest that at least 10% of wild boars in Northwestern Germany carryS. suisstrains that are potentially virulent in humans. Additional amplified fragment length polymorphism analysis supported this hypothesis, since homogeneous clustering of theepf*mrp+sly+cps2+strains from wild boars with invasive human and porcine strains was observed.
- 1 January 2007
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 56 (1) , 102-109
Amplified fragment length polymorphism of Streptococcus suis strains correlates with their profile of virulence-associated genes and clinical background
Amplified fragment length polymorphism (AFLP) typing was applied to 116 Streptococcus suis isolates with different clinical backgrounds (invasive/pneumonia/carrier/human) and with known profiles of virulence-associated genes (cps1, -2, -7 and -9, as well as mrp, epf and sly). A dendrogram was generated that allowed identification of two clusters (A and C) with different subclusters (A1, A2, C1 and C2) and two heterogeneous groups of strains (B and D). For comparison, three strains from each AFLP subcluster and group were subjected to multilocus sequence typing (MLST) analysis. The closest relationship and lowest diversity were found for patterns clustering within AFLP subcluster A1, which corresponded with sequence type (ST) complex 1. Strains within subcluster A1 were mainly invasive cps1 and mrp+ epf+ (or epf*) sly+ cps2+ strains of porcine or human origin. A new finding of this study was the clustering of invasive mrp* cps9 isolates within subcluster A2. MLST analysis suggested that A2 correlates with a single ST complex (ST87). In contrast to A1 and A2, subclusters C1 and C2 contained mainly pneumonia isolates of genotype cps7 or cps2 and epf− sly−. In conclusion, this study demonstrates that AFLP allows identification of clusters of S. suis strains with clinical relevance.
- 1 January 2007
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 56 (1) , 102-109
Amplified fragment length polymorphism of Streptococcus suis strains correlates with their profile of virulence-associated genes and clinical background
Amplified fragment length polymorphism (AFLP) typing was applied to 116 Streptococcus suis isolates with different clinical backgrounds (invasive/pneumonia/carrier/human) and with known profiles of virulence-associated genes (cps1, -2, -7 and -9, as well as mrp, epf and sly). A dendrogram was generated that allowed identification of two clusters (A and C) with different subclusters (A1, A2, C1 and C2) and two heterogeneous groups of strains (B and D). For comparison, three strains from each AFLP subcluster and group were subjected to multilocus sequence typing (MLST) analysis. The closest relationship and lowest diversity were found for patterns clustering within AFLP subcluster A1, which corresponded with sequence type (ST) complex 1. Strains within subcluster A1 were mainly invasive cps1 and mrp+ epf+ (or epf*) sly+ cps2+ strains of porcine or human origin. A new finding of this study was the clustering of invasive mrp* cps9 isolates within subcluster A2. MLST analysis suggested that A2 correlates with a single ST complex (ST87). In contrast to A1 and A2, subclusters C1 and C2 contained mainly pneumonia isolates of genotype cps7 or cps2 and epf− sly−. In conclusion, this study demonstrates that AFLP allows identification of clusters of S. suis strains with clinical relevance.